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Tareq Ibrahim, MD*
Munich, Germany
O B J E C T I V E S This study sought to compare cardiac magnetic resonance (CMR) and single-photon
emission computed tomography (SPECT) for assessment of area at risk, scar size, and salvage area after
coronary reperfusion in acute myocardial infarction.
B A C KG ROUND Myocardial salvage is an important surrogate endpoint assessing the success of
coronary reperfusion in acute myocardial infarction. SPECT, the established modality for assessment of
myocardial salvage, requires radiopharmaceutical injection before revascularization and 2 examinations.
The combination of T2 and late enhancement imaging in CMR can assess myocardial salvage in 1
examination, but up to now, data comparing both modalities are very limited.
METHOD S We analyzed 207 patients who were treated by primary revascularization in acute
myocardial infarction and who underwent both SPECT and CMR for assessment of myocardial salvage.
In CMR, T2-weighted turbo spin echo sequences for area at risk and contrast-enhanced inversion
recovery gradient echo sequences were performed.
R E S U L T S Image quality was insufﬁcient in 27 patients (13%). In the remaining 180 patients, mean area
at risk was 29.4  18.7% of the left ventricle (LV), and infarct size was 14.7  16.9% LV, resulting in a mean
salvage area of 14.9 15.1% LV in SPECT, whereas in CMR, mean area at risk was 28.0 14.5% LV, and infarct
size was 16.0  13.5% LV, resulting in a mean salvage area of 11.9  12.3%. Results of both modalities
correlated well for area at risk (r  0.80), scar size (r  0.87), and salvage area (r  0.66, all p  0.0001).
CONC L U S I O N S Assessment of the salvage area by CMR using T2 and late enhancement imaging
correlates well with the established modality of SPECT. CMR therefore may be an alternative to paired SPECT
imaging for myocardial salvage assessment, but the contraindications of the modality and limitations in the
established T2 imaging sequences currently cause a considerable rate of data loss. (J Am Coll Cardiol Img
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359rimary coronary revascularization by means
of percutaneous coronary intervention (PCI) is
a highly effective treatment of acute myocardial
infarction re-establishing coronary perfusion and
stopping the ongoing necrosis in the dependent
myocardium. Accurate assessment of the success of
revascularization is of paramount importance for
further optimization of the procedure, both the
mechanical reopening of the epicardial vessel and
the concomitant pharmacological inhibition of
platelet aggregation. Single-photon emission com-
puted tomography (SPECT) using Tc99m sesta-
mibi is the most widely used modality assessing
See page 370
myocardial salvage as the difference between the
acute perfusion defect before intervention and the
remaining scar size measured in a second scan
several days after the event. Several studies demon-
strated the accuracy of the method (1,2) and its
capability to predict mortality (3). Nevertheless, for
imaging the area at risk in acute myocardial infarc-
tion, the method requires the injection of a radio-
pharmaceutical before revascularization and image
acquisition within hours afterwards, which may
interfere with patient care and can be logistically
challenging at night.
For scar quantification, contrast-enhanced cardiac
magnetic resonance (CMR) imaging (4) offers a
well-established alternative that correlates well
with SPECT imaging (5,6). But only during
recent years has T2-weighted imaging been es-
tablished for the assessment of the cell edema
associated with acute coronary obstruction and
myocardial ischemia. Because an increased T2
signal can be demonstrated for several days after
the acute event (7), CMR offers the opportunity
to acquire images both for area at risk and for scar
size in one single examination 5 to 7 days after
the acute event. Although it could be demon-
strated that cell edema is a consistent finding in
acute myocardial infarction (8), exceeding infarct
car in size (9), the actual validation of the edema
ize is limited to experimental studies (7) and
small clinical cohorts (10,11). Therefore, the
rationale of this study was to validate the quan-
tification of the area at risk by T2 imaging in
CMR against the established modality of the
pre-interventional perfusion scan with SPECT
and to assess the correlation of the area at risk
derived from the 2 modalities in patients with
acute myocardial infarction. rM A T E R I A L S A N D M E T H O D S
Study population and design. Included in this study
ere all patients with acute ST-segment elevation
yocardial infarction (STEMI) or non–ST-segment
levation myocardial infarction (NSTEMI) undergo-
ng both contrast-enhanced CMR and Tc99m sesta-
ibi myocardial perfusion SPECT for assessment of
yocardial salvage after primary angioplasty between
ctober 1, 2006, and October 1, 2011.
All patients who were treated by primary angio-
lasty for acute myocardial infarction and had no
ontraindications for CMR (pacemaker, internal
efibrillator or other incompatible intracorporal
oreign bodies, creatinine clearance below 50 ml/
in [since May 2007], hemodynamic instability for
7 days after infarction, claustrophobia) were eli-
ible for CMR.
Patients were diagnosed with acute
yocardial infarction if they presented
ith chest pain lasting at least 20 min
ssociated with electrocardiographic
ECG) changes (ST-segment elevation,
ew-onset left bundle branch block)
nd/or elevated cardiac enzyme levels and
f the onset of symptoms was72 h before
CI (12). Patients with prior myocardial
nfarction were excluded to ensure that
MR findings displayed acute myocardial
njury. All patients gave written informed
onsent for both investigations.
Immediately after hospital admission,
ll patients were treated with PCI of the
nfarct-related artery. For the SPECT
can, patients received an intravenous in-
ection of 1,000 MBq of technetium-99m
Tc99m) sestamibi before the initiation of the
evascularization procedure. Image acquisition was
erformed within 6 to 8 h after the intervention.
he SPECT scan for scar size assessment and the
ardiac CMR were scheduled to take place 5 to 7
ays after PCI.
Hypertension, hypercholesterolemia, diabetes,
nd a family history of premature coronary artery
isease were defined by published criteria (13–16).
atients’ individual clinical and periprocedural risk
as assessed by calculating TIMI (Thrombolysis In
yocardial Infarction) (17,18) and GRACE
Global Registry of Acute Coronary Events) risk
cores (19). The latter is a group of scores created at
he Center for Outcomes Research of the Uni-
ersity of Massachusetts in a large multinational
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360dromes for prediction of morbidity and mortality
during the initial hospital stay and during follow-
up. The GRACE score used in this study as-
sessed death or myocardial infarction between
admission and 6 months later, and includes age,
heart rate, systolic blood pressure, creatinine,
Killip class, cardiac arrest at admission, elevated
cardiac markers, and ST-segment deviation (20).
The study protocol was approved by the institu-
tional ethics committee.
Myocardial perfusion SPECT. The methods used for
he radionuclide studies have been previously de-
cribed in detail (21,22). Image acquisition was
erformed with the patient in the supine position.
ual-head camera systems with low-energy, high-
esolution collimators were used for the radionu-
lide studies. Images were acquired ECG-gated in a
4-by-64 matrix with an acquisition time of 40 s
er image. A volumetric sampling tool was applied
o create polar maps of the relative distribution of
ctivity throughout the left ventricle (LV). Each
olar map was adjusted for its own maximal value.
he size of the defect was calculated with the use of
threshold of 50%, according to previously de-
cribed methods (23,24). The difference between
hese immediate and follow-up measurements pro-
ided the degree of myocardial salvage. Initial
erfusion defect, infarct size, and degree of myo-
ardial salvage were expressed as a proportion of the
V.
Cardiac magnetic resonance. CMR was performed
n a 1.5-T system (Siemens Avanto, Siemens
edical Solutions, Erlangen, Germany) equipped
ith a dedicated cardiac phased-array surface coil.
or image acquisition, patients were positioned
n a supine position, and images were acquired at
epeated end-expiratory breath holds with ECG
ating. Area at risk was assessed using a T2-
eighted turbo spin echo sequence acquired be-
ore contrast injection (slice thickness 8 mm;
epetition time 2 RR intervals; echo time 99 ms;
mage matrix 145  192). The infarct scar was
ssessed 15 min after injection of 0.2 mmol/kg
ody weight of dimeglumingadopentetat (Magn-
vist, Bayer HealthCare Pharmaceuticals, Berlin,
ermany, until June 2009, Magnograf, Maro-
rast, Jena, Germany, thereafter) on T1-weighted
nversion-recovery turbo fast low-angle shot se-
uence (slice thickness 8 mm; repetition time 4.0
s; echo time 1.5 ms; image matrix 175  256;
ip angle 30°). The inversion time was individu-
lly adjusted to null normal myocardium. For
oth acquisitions, contiguous short-axis slices of che LV from base to apex, as well as 2- and
-chamber views of the LV, were acquired at the
ame location. The CMR study was performed
.1 days [interquartile range (IQR): 3.6 to 4.9
ays] after PCI, and the median time interval
etween CMR and the second SPECT study was
.1 h [IQR: 1.4 to 25.1 h].
For defect quantification, endocardial and epi-
ardial contours were manually traced on each of
he short-axis slices by an experienced reader.
he defect size was then calculated automatically
y comparison with manually marked, healthy
emote myocardium and was expressed as the
ercentage of total LV myocardial volume (25).
rea at risk was defined as a region of hyperen-
anced myocardium with signal intensity above 2
tandard deviations of healthy remote myocar-
ium as proposed by Friedrich et al. (9). For
nfarcted myocardium, the same algorithm was
sed with a threshold of 3 standard deviations,
ecause at this cutoff, the correlation between
MR and SPECT is best (26). In consensus with
revious studies, a defect was required to have at
east 10 contiguous myocardial pixels of increased
ignal intensity (9,27). Microvascular obstruction
s an area of hypoenhancement within the in-
arcted myocardium was delineated manually,
ince there is no robust automated detection
lgorithm available. Care was taken not to miss
issue between the manually delineated and the
utomatically detected scar areas. Microvascular
bstruction was included in the infarct size cal-
ulation. Salvage area in CMR was defined as the
ifference between T2 defect and total infarct size
ssessed by late enhancement imaging. Images of
PECT and CMR were analyzed by different
bservers blinded to the results of the other
odality. For image examples describing infarct
haracterization, see Figure 1.
Statistical analysis. Categorical variables were ex-
ressed as frequencies and percentages, continuous
ariables were expressed as mean  SD or, for the
ore skewed clinical parameters and time intervals,
s median [IQR]. Comparison between continuous
ariables was done using the Student t test or
ilcoxon test as appropriate; for categorical vari-
bles, the Fisher exact test was used. Correlation
etween CMR and SPECT was calculated using a
inear regression model. Correlation coefficients
ere compared using Fisher’s Z-transform (28);
orrelation with clinical parameters was calculated
sing Spearman’s r. Statistical significance was ac-
epted for 2-sided p values 0.05. The statistical
ion
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361package R version 2.10.1 (29) was used for statis-
tical analysis.
R E S U L T S
Study population and clinical characteristics. During
the study period, 1,368 patients with acute myocar-
dial infarction were treated by primary PCI. Of
these, 254 had a recurrent infarction; 441 of the
1,114 patients with primary infarction underwent
SPECT imaging for assessment of area at risk and
scar size. From these, 207 patients also underwent
CMR for T2 imaging and late enhancement imag-
ing. Of these, 27 were excluded because the image
quality of the CMR study was insufficient for
automated analysis (all in T2 studies), resulting in a
study population of 180 patients.
From the 441 patients undergoing SPECT, 26
patients (6%) had creatinine levels above 1.5 mg/dl
at the time of discharge, 8 patients (2%) had a
permanent pacemaker or an internal defibrillator, so
Figure 1. Image Examples
Image examples of area at risk and myocardial scar. Top row: or
hanced gradient echo sequence right). Middle row: semiautoma
pink area denotes manually drawn area of microvascular obstru
sion computed tomography (SPECT) images. The patient in A ha
rior wall and peak creatine kinase of 1,510 U/l; area at risk visibl
[MV]) and SPECT (69% MV) was mostly transmural, scar quantiﬁe
piration and revascularization of a thrombotically occluded left a
the anterior wall and peak creatine kinase of 8,600 U/l, SPECT sh
in CMR, a transmural scar (48% MV) and an area at risk of simila
akinesia of the anterior wall and a left anterior descending arter
vention was uncomplicated and successful. The patient in C had
intervention of 2 h, and peak creatine kinase of 1,700 U/l. T2 CM
too low to be completely detected automatically (calculated as 8
subendocardial scar is quantiﬁed similarly, both by CMR (12% M
occlusion of the medial right coronary artery; coronary interventin total, 8% of the patients undergoing SPECT mwere ineligible for CMR. Reasons for not perform-
ing CMR in the remaining patients were missing
consent of the patients because of claustrophobia or
other reasons, and logistical problems in scheduling
the exam before discharge.
The age of the patients was 61 [IQR: 52 to 70]
years, and 139 patients (77%) were male. The
majority of the patients (149, or 87%) presented in
stable condition in Killip class 1. STEMI was
diagnosed in 121 patients (67%), whereas 59 pa-
tients (33%) had NSTEMI. A detailed summary of
the patients’ characteristics is provided in Table 1.
The infarct location was anterior in 73 patients (40%),
inferior in 84 patients (47%), and lateral in 23 patients
(13%). PCI was performed 4.9 [IQR: 3.4 to 8.0] h
after onset of symptoms in the STEMI group and
12.6 [IQR: 8.4 to 23.6] h after onset of symptoms in
the NSTEMI group. For further details of the infarct
characteristics, please refer to Table 2.
Results of SPECT and CMR. In SPECT imaging,
al image (T2-weighted turbo spin sequence left, contrast-en-
quantiﬁcation (red area denotes automatically detected lesion,
). Bottom row: corresponding sestamibi single-photon emis-
-segment elevation myocardial infarction (STEMI) of the ante-
cardiac magnetic resonance (CMR) (53% of myocardial volume
54% MV in CMR and 55% MV in SPECT. Successful thromboas-
rior descending coronary artery. The patient in B with STEMI of
an area at risk (37% MV) smaller than the scar size (52% MV);
e (50% MV) are visible. Coronary intervention shows a marked
th a high-grade stenosis and TIMI ﬂow grade 2. Coronary inter-
rior wall STEMI, time interval between start of symptoms and
hows cell edema of the basal inferior wall with signal intensity
V), whereas in SPECT, a larger defect of 31% MV is visible,
nd SPECT (10% MV). Coronary angiography revealed a subtotal
was uncomplicated and successful.igin
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362size was 14.7  16.9% LV, resulting in a mean
salvage area of 14.9  15.1% LV. In the CMR
studies, mean area at risk was 28.0  14.5% LV,
Table 1. Clinical Characteristics and Conventional Risk Scores
All Patients
(N  180)
Age, yrs 60.5 [51.5–69.8]
Male 139 (77)
BMI, kg/m2 27.2 [24.7–29.3]
Arterial hypertension 60 (33)
Diabetes 25 (14)
Current smoker 72 (40)
Hypercholesterolemia 86 (48)
Family history of premature CAD 72 (40)
Prior revascularization 18 (10)
Systolic blood pressure, mm Hg 131 [120–150]
Heart rate, beats/min 76 [66–85]
Creatinine, mg/dl 0.9 [0.8–1.0]
Killip class before PCI
1 149 (87)
2 19 (11)
3 4 (2)
GRACE score 144 [117–166]
TIMI risk score 3 [1–5]
Values are median [interquartile range] or n (%).
BMI body mass index; CABG coronary artery bypass graft; CAD coronary arter
elevation myocardial infarction; PCI  percutaneous coronary intervention; STEMI  S
Table 2. Infarct Characteristics
All Patients
(N  180)
Infarct location
Inferior 84 (47)
Lateral 23 (13)
Anterior 73 (40)
Cardiac markers (before PCI)
CK, U/l 212 [116–496]
CK-MB, U/l 26 [17.5–59.2]
Troponin T, ng/ml 0.15 [0.04–0.55]
Time to balloon, h 5.92 [3.93–12.7]
TIMI ﬂow before PCI
0 85 (47)
1 18 (10)
2 46 (26)
3 31 (17)
TIMI ﬂow grade post-PCI
0 2 (1.1)
1 3 (1.7)
2 15 (8)
3 160 (89)
EF before angioplasty, % 48 [42–55]
Values are median [interquartile range] or n (%).
CK  creatine kinase; CK-MB  creatine kinase myocardial band; EF  ejection fraand total infarct size was 16.0  13.5% LV,
esulting in a mean salvage area of 11.9  12.3%.
or the area at risk, there was no significant
NSTEMI STEMI
p Value(n  59) (n  121)
62.2 [53.1–70.0] 58.6 [50.6–69.8] 0.29
40 (68) 99 (82) 0.039
27.1 [25.5–28.9] 27.2 [24.6–29.4] 0.57
19 (32) 41 (34) 0.87
11 (19) 14 (12) 0.25
18 (31) 54 (45) 0.077
33 (56) 53 (44) 0.15
23 (39) 49 (41) 0.87
7 (12) 11 (9) 0.6
140 [128–150] 130 [120–146] 0.036
76 [67–85] 75 [64–85] 0.67
0.9 [0.8–1.0] 0.9 [0.8–1.1] 0.17
0.13
48 (92) 101 (84)
4 (8) 15 (13)
0 (0) 4 (3)
131 [109–159] 149 [122–170] 0.027
2 [1–4] 3 [1–5] 0.30
ease; GRACE Global Registry of Acute Coronary Events; NSTEMI non–ST-segment
ment elevation myocardial infarction; TIMI  Thrombolysis In Myocardial Infarction.
NSTEMI STEMI
p Value(n  59) (n  121)
0.21
28 (48) 56 (46)
9 (15) 12 (10)
22 (37) 53 (44)
370 [210–632] 173 [103–379] 0.0001
40.5 [25.7–70.3] 21.8 [16.4–49.9] 0.00033
0.37 [0.15–0.84] 0.08 [0.03–0.37] 0.0001
12.6 [8.43–23.6] 4.92 [3.40–8] 0.0001
0.026
24 (41) 61 (50)
2 (3.4) 16 (13)
20 (34) 26 (22)
13 (22) 18 (15)
0.64
0 (0) 2 (1.6)
2 (3.39) 1 (0.8)
3 (5) 12 (10)
54 (92) 106 (88)
50 [45–58] 48 [42–55] 0.055y disction; other abbreviations as in Figure 1.
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363difference between CMR and SPECT (difference
1.4  11.3, p  0.084). CMR slightly overesti-
mated infarct size when compared with SPECT
(difference 1.3  8.4, p  0.038), resulting in a
significantly smaller salvage area in CMR when
compared with SPECT (difference 2.8  11.5,
p  0.0015).
Expressed as median and IQR, the size of the
area at risk was 27.5% [IQR: 15.0 to 44.0] LV in
SPECT and 28.9% [IQR: 18.6 to 39.4] LV in
CMR (p  0.97 for difference); infarct size was
7.0% [IQR: 1.7 to 25.0] LV in SPECT and 12.7%
[IQR: 5.2 to 24.6] LV in CMR (p  0.06 for
difference), and salvage area was 9.0% [IQR: 3.0 to
16.5] LV in SPECT and 10.6% [IQR: 4.7 to 18.4]
LV in CMR (p  0.22 for difference).
Despite the overall good correlation between the
2 modalities, there were substantial differences in
individual cases, as demonstrated in the imaging
examples in Figure 1.
Although both area at risk and scar size were
larger in STEMI patients than in NSTEMI pa-
tients (all p  0.009), the salvage area showed no
significant difference in both groups (p  0.66 for
SPECT and p  0.82 for CMR). A detailed
summary of the SPECT and CMR results is
provided in Table 3.
Area at risk correlated well in both modalities
(r  0.80, p  0.0001). Similar results were found
for the scar size (r 0.87, p 0.0001). Correlation
for salvage area was slightly weaker (r  0.66);
CMR underestimated the salvage area by more than
10% LV in 45 patients (25%) and overestimated by
more than 10% LV in 24 patients (13%) when
compared with SPECT (Fig. 2).
For external validation of the results, both mo-
dalities were compared with cardiac enzymes and
Table 3. SPECT and CMR Results
All Patients
(N  180)
Area at risk
SPECT area at risk 29.4 18.7
CMR T2 imaging 28.0 14.5
Infarct size
SPECT scar 14.7 16.9
CMR infarct total size 16.0 13.5
Salvage area
SPECT (area at risk  scar) 14.7 15.1
CMR (size T2  size total scar) 11.9 12.3
Values are mean  SD. Defect size is given as the percentage of total left ven
CMR  cardiac magnetic resonance; SPECT  single-photon emission compucardiac function, as summarized in Table 4. Forassessment of the area at risk, both SPECT and
CMR T2 had no significant correlation with the
initial cardiac markers, but a good correlation with
the ejection fraction before PCI (r0.61 and r
0.46, respectively). For scar size, both SPECT
and CMR late enhancement correlated well with
peak creatine phosphokinase (r  0.64 and r 
.72, respectively) and ejection fraction at the time
f CMR (r  0.55 and r  0.54, respectively).
A subgroup analysis of the area at risk showed a
onsistently good correlation between the 2 modal-
ties for different clinical parameters. There was no
ignificant difference in correlation when comparing
atients with STEMI and NSTEMI (r  0.80 vs.
 0.76, p  0.52) and patients with a pre-
interventional TIMI flow grade of 0 and a TIMI
flow grade1 (r 0.75 vs. r 0.82, p 0.41), but
here was a trend towards a better correlation in
atients with anterior and lateral wall infarction
hen compared with patients with inferior wall
nfarction (r 0.80 vs. r 0.69, p 0.10) (Fig. 3).
Looking at the correlation to the time interval
etween start of symptoms and start of interven-
ions, there was no significant correlation found
n both modalities for the area at risk (r  0.05,
 0.48 for T2 CMR, r  0.08, p  0.30 for
SPECT), scar size (r  0.04, p  0.58 for late
gadolinium enhancement CMR, r  0.01, p 
0.92 for SPECT), or salvage area (r  0.11, p 
0.14 for CMR, r  0.11, p  0.16 for SPECT)
(Fig. 4).
D I S C U S S I O N
The key finding of this study is that both the area at
risk assessed by T2 imaging in CMR and the
salvage area calculated from the difference between
NSTEMI STEMI
p Value(n  59) (n  121)
24.2 18.2 31.9 18.4 0.0092
21.7 12.8 31 14.2 0.0001
9.15 11.6 17.4 18.4 0.00034
10.4 8.9 18.8 14.5 0.0001
15.1 16.6 14.5 14.5 0.82
11.3 13.2 12.2 12.0 0.66
ar myocardial volume.
omography; other abbreviations as in Figure 1.triculthis measurement and the total scar size in contrast-
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364enhanced CMR correlate well with the established
method using Tc99m sestamibi SPECT.
Area at risk. T2-weighted imaging in CMR (30)
nd the acute perfusion scan in SPECT (23,31)
ssess slightly different pathophysiological changes
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Figure 2. Correlation Between SPECT and CMR
Studies for area at risk (A), scar size (B), and salvage area (C), displayed
Figure 1.f acute myocardial infarction. Triggered by an icute occlusion of an epicardial coronary artery,
here will be impaired cellular metabolism causing
lectrolyte imbalances, release of water from protein
indings, and endothelial leakage, all leading to
reversible) cell swelling detectable by T2-weighted
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xy-plots (left) and Bland-Altman plots (right). Abbreviations as inasmaging (7,32–34). Although it could be demon-
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365strated in experimental studies that cell edema is
detectable as early as 30 min after total occlusion of
a coronary artery (35), the pathophysiological
changes in clinical infarction are more variable,
including subtotal coronary occlusion or spontane-
ous lysis of a total occlusion after varying time
intervals (36,37). But it is also well known that the
changes in T2 imaging persist for days and some-
times weeks after reperfusion, even when functional
metabolism is recovering (7). Sestamibi, on the
other hand, is easily incorporated into myocytes,
but accumulates in the mitochondria because it
cannot be metabolized further. Because sestamibi is
rapidly excreted from blood circulation after injec-
tion, distribution in the myocardium is mainly
influenced by the myocardial blood flow in the
minutes after injection (38). Both methods may
therefore produce different results in certain cir-
cumstances. CMR may show a smaller area at risk
than SPECT in case of a very acute occlusion
(which may not coincide with the start of symp-
toms); this may be the case in patient C in Figure 1.
It may also show a larger area at risk after sponta-
neous lysis of a longer-lasting total occlusion or in
case of a subtotal occlusion still allowing a basal cell
metabolism. The inconclusive findings in patient B
in Figure 1 could be explained by spontaneous lysis
because the wall motion abnormality is out of
proportion to the observed TIMI flow grade 2 distal
to the culprit lesion.
Despite these methodical limitations, there was
no significant difference in the area at risk between
both modalities, and we found a good correlation
between the 2 modalities. In addition, area at risk
Table 4. Correlation With Cardiac Enzymes and Cardiac Functio
SP
Spearman’s r
Area at risk
Initial CK 0.05
Initial CK-MB 0.12
Ejection fraction before PCI 0.61
Infarct size
Peak CK 0.64
Peak CKMB 0.63
Ejection fraction after PCI 0.55
End-diastolic volume index after PCI 0.34
End-systolic volume index after PCI 0.52
Correlation is between SPECT and external parameters, and CMR and external p
edema in CMR T2 imaging were used; for infarct size, defect size in post-PCI S
Abbreviations as in Figures 1, 2, and 3.derived from both modalities correlated equally wellwith pre-intervention ejection fraction as a param-
eter for external validation.
There was a slight overestimation of the area at
risk by CMR as compared with SPECT; this may
be explained by the myocardial swelling, which
leads to a thickening of the affected LV wall. This
wall thickening is incorporated into the volumetric
analysis of CMR but may be missed by the surface
area–based quantification algorithm of SPECT.
Another explanation could be an overestimation by
detection of peri-infarct inflammation as suggested
by Mewton et al. (39).
Our results confirm on a large scale 2 smaller
studies by Carlsson et al. (10) and Sörensson et al.
(11), who demonstrated similar correlations be-
tween manually traced lesions in CMR T2 imaging
and SPECT in groups of 16 patients each. In
addition, Berry et al. (40) found a similarly strong
correlation (r 0.77) between the area at risk assessed
by T2-weighted CMR and the APPROACH (Al-
berta Provincial Project for Outcome Assessment in
Coronary Heart Disease) lesion score, which estimates
the area at risk by the actual location of the culprit
lesion.
Scar size and salvage area. For scar size quantifica-
tion, we could reproduce the good correlation
between contrast-enhanced CMR and SPECT de-
scribed by Ibrahim et al. (6) in a larger patient
population. The same as described in their study,
we found a slight overestimation of small scar size
in CMR that can be explained by the higher spatial
resolution of CMR compared with SPECT, result-
ing in the detection of small subendocardial scars
missed by SPECT. Scar size in both modalities
CMR
p Value Spearman’s r p Value
0.52 0.03 0.72
0.12 0.06 0.41
0.0001 0.46 0.0001
0.0001 0.72 0.0001
0.0001 0.73 0.0001
0.0001 0.54 0.0001
0.0001 0.26 0.0007
0.0001 0.47 0.0001
eters, respectively. For area at risk, defect size in pre-PCI SPECT and size of cell
and scar size in CMR late enhancement were used.n
ECT
aram
PECTcorrelated equally well with functional parameters
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366such as ejection fraction and end-systolic volume
index and enzymatic infarct size.
There are several studies published assessing
myocardial salvage assessed by CMR. Friedrich et
al. (9) analyzed 92 patients with acute myocardial
infarction and successful reperfusion, and found an
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Figure 3. Subgroup Analysis for Area at Risk
Correlation between SPECT and CMR studies for the area at risk: NS
localization (C). NSTEMI  non–ST-segment elevation myocardial in
tions as in Figure 1.area at risk consistently larger than the scar size inall patients, resulting in a salvage area of 16  11%
LV. Eitel et al. (41) analyzed 208 STEMI patients
undergoing primary angioplasty and identified
myocardial salvage, infarct size, and microvascular
obstruction assessed by CMR as good predictors of
major cardiac events during a 6-month follow-up.
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367between myocardial salvage assessed by CMR and
LV dysfunction 6 months after the event in 101
patients undergoing early revascularization in
STEMI, whereas acute LV function and the size of
late gadolinium enhancement and microvascular
obstruction showed better correlations.
But to date, no data exist on the direct compar-
ison between myocardial salvage assessed by CMR
and the current gold standard of SPECT. We
compared the salvage areas derived from both
modalities in a population of 180 patients with
successful reperfusion in acute myocardial infarc-
tion, and despite the aforementioned methodical
differences, we found a reasonably good correlation
between the 2 modalities; but in 38% of the
patients, the results of both methods diverged by
more than 10% of the LV volume, a difference that
may be clinically significant. Although the weaker
correlation between the 2 modalities in this derived
parameter can easily be explained mathematically,
the timing of the examination may be an additional
confounder. Infarct healing is still in progress dur-
ing the first week after infarction, and infarct size as
measured by CMR decreases by about 7% between
day 1 and 7 (43). Therefore, the time interval
between CMR and SPECT measurement may add
to the variability between the 2 modalities.
The suboptimal correlation between CMR and
SPECT has to be kept in mind when assessing the
success of a coronary intervention by CMR.
Follow-up studies are clearly needed to finally
validate this method.
Limitations of CMR. For assessment of salvage area,
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Figure 4. Time to Balloon Versus Salvage Area
Correlation between time to balloon (time interval between onset o
and SPECT studies (right). Abbreviations as in Figure 1.MR has 2 clear advantages over SPECT. It is not associated with radiation exposure and only needs 1
xam about 5 days after the acute event when acute
herapy normally is finished and the patient is fairly
tabilized. But there are clear drawbacks, too. First,
MR has additional contraindications compared
ith SPECT, most of all the presence of pacemak-
rs and implantable defibrillators and an impaired
enal function. In addition, the procedure is not
lways tolerated well by the patients, due to claus-
rophobia or reluctance against a long examination,
hich may further complicate patient recruitment.
f all patients undergoing SPECT during the
tudy period, 2% of the patients had a pacemaker or
efibrillator, and 6% had impaired renal function at
ischarge.
Second, the T2-weighted turbo spin echo se-
uence has a low contrast-to-noise ratio, necessi-
ating a quite low threshold of 2 SD for edema
etection and is prone to artifacts that may neces-
itate individual sequence adjustments. Tachycar-
ia, arrhythmias, and the sequelae of hemodynamic
mpairment such as pleural effusion or congestive
eart failure, all common, particularly after large
nfarctions, limit the image quality or prevent a
alid image analysis at all. The exclusion rate of
3% because of insufficient image quality found in
ur analysis clearly limits the use of CMR as a
urrogate endpoint in a clinical study.
There are new, promising developments in se-
uence technology that probably improve image
uality, namely T2 mapping sequences and auto-
ated motion correction algorithms. These im-
rovements may provide the robustness to depend-
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mptoms and intervention) and salvage area for CMR studies (left)f sybly examine even hemodynamically compromised
DJ A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 6 , N O . 3 , 2 0 1 3
M A R C H 2 0 1 3 : 3 5 8 – 6 9
Hadamitzky et al.
Myocardial Salvage in CMR and SPECT
368patients and allow for further simplification and
standardization, both of image acquisition and
analysis.
C O N C L U S I O N S
We could demonstrate that the assessment of the
area at risk by T2-weighted CMR imaging in
CMR correlates well with the established modality
of SPECT in patients undergoing primary PCI in
acute myocardial infarction. A reasonably good
correlation could be found between the salvage area
derived from T2 imaging and scar quantification byweighted cardiac magnetic resonance
1
1
1
E1–211.area derived from SPECT. CMR may therefore be
an alternative to paired SPECT imaging for myo-
cardial salvage assessment, but the contraindica-
tions of the modality and limitations in the estab-
lished T2 imaging sequences currently may cause a
considerable rate of data loss.
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